Our Programs
Advancing Diagnostics.
Transforming Lives.
Senticell is developing next-generation liquid biopsy solutions powered by Red Cell-Bound Nucleic Acids (RBC-NAs). Our disease-focused programs are designed to enable earlier detection, improve diagnostic precision, and support better clinical outcomes across high-impact medical conditions.
Disease Programs
Our research and development efforts are focused on diseases where early, accurate, and minimally invasive diagnostics can make a meaningful difference to patient care. Leveraging the unique biology of red blood cells, Senticell is building a robust pipeline of diagnostic programs addressing critical unmet clinical needs.
Oncology
-
Lung Cancer
-
Pancreatic Cancer
-
Cervical Cancer
-
Head & Neck Cancer
Infectious Diseases
-
Sepsis
-
Tuberculosis
-
COVID-19
Cystic Fibrosis
-
Biomarker Discovery
-
Early Disease Detection
-
RBC-Based Molecular Diagnostics